内镜辅助鞘在高血压脑出血脑内血肿清除术中的应用

doi:10.3969/j.issn.1001-8131.2024.03.011

Abstract
Figure/Table
References
Related Citation (6)

Download: PDF (587 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective Analysis of endoscope assisted sheath in hypertensive intracerebral hemorrhage（HICH）the application of brain hematoma removal. Methods A study was conducted on 89 patients with hypertensive intracerebral hemorrhage .The patients were divided into two groups based on whether a new adjustable neuroendoscope-assisted sheath was used during the hematoma clearance surgery：the sheath group（n=47）and the non-sheath group（n=42）.The study aimed to compare the surgical conditions,clinical indicators,complications,and prognosis of the two groups. Results The surgical time and intraoperative blood loss of the sheath group were less than those of the non-sheath group,and the hematoma clearance rate was significantly higher than that of the non-sheath group（P<0.05）.Compared with before the surgery,the sepsis organ function failure score（SOFA）,the Acute Physiology and Chronic Health Evaluation Ⅱ（APACHE-Ⅱ）,and the National Institutes of Health Stroke Scale（NIHSS）score of both groups significantly decreased after the surgery,and the scores in the sheath group were lower than those in the non-sheath group（P<0.05）.The incidence of intracranial infection,epilepsy,pulmonary infection,and stress ulcers in the sheath group was significantly lower than that in the non-sheath group（P<0.05）.The prognoses of patients in the sheath group with grades Ⅱ-V were 3,9,21,and 14,respectively,while those in the non-sheath group were 11,15,11,and 5,respectively.The difference between the two groups in prognosis was statistically significant（P<0.05）. Conclusion The clinical practical value of the new adjustable neuroendoscopic-assisted sheath in the treatment of HICH intracerebral hematoma clearance surgery is high,which can expand the clinical application range and improve the clinical surgical treatment efficiency.

Key words： The new adjustable neural endoscope assisted sheath Removal of brain hematoma Hypertensive cerebral hemorrhage Clinical application

Received: 25 May 2023

PACS:

R544.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Du Zhanfeng
	Wang Maode
	Jiang Haitao
	Wang Tuo
	Li Qi

Cite this article:

Du Zhanfeng,Wang Maode,Jiang Haitao, et al. Endoscopy Assisted Sheath in the Application of Hypertension Cerebral Hemorrhage Brain Hematoma Removal[J]. journal1, 2024, 44(3): 32-35.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2024.03.011 OR http://www.hrbyybjb.org.cn/EN/Y2024/V44/I3/32

[1] 胡志卿,范学政,李明,等.神经内镜辅助3D-slicer导航在高血压脑出血手术中的应用及预后分析[J].神经损伤与功能重建,2021,016(12):756-758.
[2] 匡德利,许西海,符艳松.神经内镜辅助去骨瓣血肿清除术治疗高血压脑出血的效果及对患者神经功能、预后的影响[J].临床误诊误治,2021,34(5):106-111.
[3] 吴瑞,王静茹,吴琦.基于神经内镜下血肿清除术对中央型高血压脑出血患者的临床效果及相关并发症的影响研究[J].山西医药杂志,2022,51(19):2216-2219.
[4] 徐伟光,钟德泉,赵展.脑CT三维定位贴在神经内镜治疗高血压脑出血中的应用研究[J].中国内镜杂志,2022,28(4):8-12.
[5] Castello JP,Pasi M,Kubiszewski P,,et al.Cerebral Small Vessel Disease.Cerebral Small Vessel Disease and Depression Among Intracerebral Hemorrhage Survivors.Stroke.2022 Feb;53(2):523-531.
[6] 赵朝辉,阳建国,钟兴明,等.神经内镜微创与小骨窗开颅显微手术治疗高血压脑出血及其不同部位血肿的疗效[J].临床神经外科杂志,2021,18(5):572-576.
[7] 席增辉,李洋,倪海涛.高血压脑出血神经内镜微创手术与开颅血肿清除术临床效果比较[J].中国药物与临床,2021,21(12):2126-2127.
[8] 江楠,黄敏东,蔡丹辉,等.神经内镜微创手术治疗高血压脑出血的疗效及血清IL-10、IL-17、BDNF、S100β蛋白水平变化研究[J].湖南师范大学学报:医学版,2021,18(2):55-58.
[9] 金二亮,潘万喜,周健,等.神经内镜手术及外侧裂入路开颅术治疗基底节高血压脑出血的疗效[J].川北医学院学报,2022,37(9):1127-1130.
[10] 赵广平,刘盼盼,刘飞,等.高血压脑出血立体定向颅内血肿清除术中不同麻醉方式的血流动力学及应激反应[J].昆明医科大学学报,2022,43(5):117-122.
[11] 吴永,许勇,邱大志,等.神经内镜辅助下手术与小骨窗手术治疗高血压脑出血的疗效比较[J].安徽医学,2021,42(5):527-530.
[12] 王文举,蔡强,李知阳,等.3D-slicer软件辅助神经内镜在幕上高血压性脑出血个体化治疗中的应用价值[J].中国医药,2022,17(9):1356-1360.
[13] 蒋耀峰,沈洋,董誉,等.神经内镜下经外侧裂入路血肿清除术治疗高血压脑出血的临床疗效和预后分析[J].局解手术学杂志,2021,30(6):494-497.

[1]	. [J]. journal1, 2023, 43(6): 111-113.
[2]	. [J]. journal1, 2023, 43(6): 143-144.
[3]	. [J]. journal1, 2023, 43(5): 140-142.
[4]	. [J]. journal1, 2023, 43(1): 86-87.
[5]	. [J]. journal1, 2022, 42(6): 56-57.
[6]	. [J]. journal1, 2022, 42(1): 141-142.